INTEGRATIVE APPROACH TO FIND PREDICTIVE MARKERS OF RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA
Published date:
05/12/2021
Excerpt:
We retrospectively included 97 multiple myeloma patients treated with Dara...Similarly, expression of CD27 and CD45 were significantly associated with poor response to Dara.